Ischemia-reperfusion injury (IRI) IRI followed by reperfusion can induce massive cell death and inflammatory response in affected organs, resulting in severe diseases including IRI-induced heart disease, kidney diseases, lung diseases and liver diseases [242]
Label warnings to know: Thyroid C-cell tumor warning (avoid if personal/family history of medullary thyroid carcinoma or MEN2) Pancreatitis riskseek immediate care for severe abdominal pain Gallbladder disease Dehydration/acute kidney injury risk with persistent vomiting or diarrhea Drug interactions: Birth control (tirzepatide): Oral contraceptives may be less effective around initiation and each dose increase
Animal study doses: Nearly all BPC-157 research uses rats at 10 mcg/kg (the standard research dose), with some studies going up to 50 mcg/kg
The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting properties
Serious but rare adverse effects associated with injectable GLP-1 receptor agonists include acute pancreatitis, gallbladder disease (cholecystitis and cholelithiasis), and potential thyroid effects